• 42
  • 7
  • Favorite

辉瑞研发新冠疫苗增强剂,以应对德尔塔变异病毒

新浪财经2021-07-09

辉瑞及其合作伙伴BioNTech周四宣布,他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂,因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。 两家公司表示,尽管他们认为目前的两剂疫苗如果施打第三剂有可能对包括德尔塔在内的所有已知变种保持“最高水平”的保护,但他们仍在“保持警惕”,并正在开发一种更新版本的疫苗。 两家公司表示,临床研究最早可能于8月开始,但需获得监管机构的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment7

  • EliTan
    ·2021-07-09
    Good
    Reply
    Report
    Fold Replies
    • EliTan
      hao
      2021-07-09
      Reply
      Report
  • EliTan
    ·2021-07-09
    Good
    Reply
    Report
  • HuiYin296
    ·2021-07-09
    ??
    Reply
    Report
  • 甜甜圈大
    ·2021-07-09
    加油
    Reply
    Report
  • Jessie8590
    ·2021-07-09
    [微笑] 
    Reply
    Report
  • Kenny52041
    ·2021-07-09
    power~~
    Reply
    Report
  • Eileen1026
    ·2021-07-09
    ????
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial